Form 4: Silvaco Group Director Ngai-Pesic Sells 25,000 Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Katherine Ngai-Pesic, a director and member of a 10% owner group of Silvaco Group, Inc., sold 25,000 shares of common stock at an average price of $5.0648 per share on March 14, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

  • On March 14, 2025, Katherine Ngai-Pesic, a director and member of a 10% owner group of Silvaco Group, Inc., sold 25,000 shares of common stock.
  • The sale was executed under a 10b5-1 trading plan established on December 12, 2024.
  • The shares were sold at a weighted average price of $5.0648, with individual transaction prices ranging from $4.96 to $5.17.
  • Following the transaction, Ngai-Pesic beneficially owns 10,461,105 shares of Silvaco Group, Inc.
  • The 10b5-1 plan allows for the potential sale of up to 180,000 additional shares if the stock price reaches certain levels between $9.98 and $19.98.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a pre-planned stock sale under a 10b5-1 plan. There is no indication of positive or negative sentiment towards the company's prospects.

Risks

  • The potential sale of up to 180,000 additional shares under the 10b5-1 plan could exert downward pressure on the stock price if the price targets are met.

Future Outlook

The reporting person may sell up to 180,000 additional shares under the 10b5-1 plan if the stock price reaches certain levels between $9.98 and $19.98.

Industry Context

Insider sales are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares in a pre-planned manner to avoid accusations of trading on non-public information. The market will often scrutinize these sales for any potential signals about the company's future prospects.

Comparison to Industry Standards

  • Comparing Silvaco Group to similar companies in the semiconductor or technology sector, insider trading activity is a common occurrence.
  • Companies like Cadence Design Systems or Synopsys often see similar filings from their executives and directors.
  • The size of the transaction (25,000 shares) is relatively small compared to the overall outstanding shares, suggesting it may not have a significant impact on the stock price.

Stakeholder Impact

  • The sale could have a minor negative impact on shareholder sentiment, although the pre-planned nature of the sale mitigates this concern.
  • The impact on employees, customers, suppliers, and creditors is likely to be negligible.

Key Dates

DateDescription
2024-12-12Date of the 10b5-1 Plan
2025-03-14Date of the stock sale transaction
2025-03-14Date of Power of Attorney execution

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.